Mechanistic insights on lycopene usage against diabetes and associated complications
- PMID: 39868352
- PMCID: PMC11759726
- DOI: 10.1007/s40200-025-01561-4
Mechanistic insights on lycopene usage against diabetes and associated complications
Abstract
Lycopene is a tetraterpene compound belonging to carotenoids that are widely present in tomatoes and similar products. It is known as a powerful anti-oxidant and a non-provitamin A carotenoid. Lycopene has been found to effectively improve diabetes mellitus and its complications, such as cardiac complications, disorders caused by oxidative stress, and liver and neurological disorders. Furthermore, free radicals have been shown to disrupt the action of insulin by changing the physical state of the target cell membrane, while carotenoids improve insulin secretion and function in blood sugar regulation by neutralizing free radicals. It, therefore, seems that targeted clinical studies are needed to investigate the therapeutic effect of lycopene against metabolic disorders induced by diabetes. This review aims to summarize information on the sources and potential uses of lycopene and the possible mechanisms involved in the reduction of the above diseases. Its protective effects, in terms of toxicity and safety, are also discussed. The literature sources used in this review were PubMed, Google Scholar, Scopus, and Web of Science databases.
Keywords: Inflammation; Insulin; Lycopene; Neuropathy; Oxidative stress; Streptozotocin; Type 2 diabetes.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare that they do not have any conflict of interest.
References
-
- Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda BIDF. Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. - PubMed
-
- Sanlier N, Gencer F. Role of spices in the treatment of diabetes mellitus: a minireview. Trends Food Sci Technol. 2020;99:441–9.
-
- Baradaran Rahimi V, Askari VR. A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor beta-caryophyllene. BioFactors. 2022;48(4):857–82. - PubMed
-
- Rakhshandeh H, Rajabi Khasevan H, Saviano A, Mahdinezhad MR, Baradaran Rahimi V, Ehtiati S, Etemad L, Ebrahimzadeh-Bideskan A, Maione F, Askari VR. Protective effect of Portulaca oleracea on Streptozotocin-induced type I diabetes-associated reproductive system dysfunction and inflammation. Molecules. 2022;27(18):6075. - PMC - PubMed
-
- Bashir SO. Concomitant administration of resveratrol and insulin protects against diabetes mellitus type-1-induced renal damage and impaired function via an antioxidant-mediated mechanism and up-regulation of Na+/K+-ATPase. Arch Physiol Biochem. 2019;125(2):104–13. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
